The store will not work correctly when cookies are disabled.
Important Safety Information for Users of FreeStyle Libre Readers: To learn how to safely store, charge and use your Reader, please click HERE for more info. ADC-76399 v1.0
Clinical studies show glucose monitoring are associated with better outcomes25. They also indicate that regular glucose testing is essential26, 27 to better manage overall glucose levels and reduce diabetes-related complications. With the FreeStyle Libre system, glucose monitoring is made easier.
FreeStyle Libre improves the frequency of glucose monitoring.
Two clinical studies, IMPACT and REPLACE, demonstrated that T1DM and T2DM FreeStyle Libre users safely and successfully replaced routine SMBG28.
FreeStyle Libre users monitored their glucose almost three times as frequently compared to self-monitored blood glucose (SMBG)28.
FreeStyle Libre users also reduced routine finger pricks by over 90%, with no device-related serious adverse events29, 30.
The FreeStyle Libre system delivers important clinical benefits
The studies showed that T1DM and T2DM FreeStyle Libre users spent less time in hypoglycaemia, had fewer hypoglycaemic episodes per day, and saw no statistically significant increase in HbA1c vs SMBG 29, 30.
Both T1DM and T2DM FreeStyle Libre users spent significantly less time in hypoglycemia (<3.9 mmol/L)29, 30.
Both T1DM and T2DM FreeStyle Libre users have fewer hypoglycaemic episodes per day (<3.9 mmol/L)29, 30.
Real-World data from Abbott's FreeStyle Libre show association between higher frequency of glucose monitoring and improved glucose control for people with diabetes31.
More scanning: users checked their glucose levels an average of 16 times a day31.
Reduction in hypoglycemia
Time spent below glucose levels of 3.9 mmol/L, 3.0 mmol/L and 2.5 mmol/L decreased by 15%, 40% and 49%31.
IMPROVED eHbA1c
Average glucose level decreased as scan rate increased, with estimated HbA1c decreasing from 8.0% to 6.7%31.
References:
25 Miller KM, et al. Evidence of a strong association between frequency of self-monitoring and hemoglobin A1c levers in T1D Exchange clinic registry participants, Diabetes Care. 2013; 36(7):2009-2014.
26 Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ. 2004;30(1):112-125.
27 Wagner J, Malchoff C, Abbott G. Invasiveness as a barrier to self-monitoring of blood glucose in diabetes.Diabetes Technol Ther. 2005;7(4):612-619.
28 Bolinder, Jan., et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. The Lancet 388.10057 (2016): 2254-2263.
29 Data on file, Abbott Diabetes Care. An Evaluation of a Novel Glucose Sensing Technology in Type 1 Diabetes (IMPACT). [Clinical Trial Identifier: NCT02232698].
30 Data on file, Abbott Diabetes Care. An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes (REPLACE). [Clinical Trial Identifier: NCT02082184].
31 Dunn, T. et al. (2017). Evidence of a strong association between frequency of flash glucose monitoring and glucose control measures during real-world usage. E-poster presentation, The 10th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2017) Paris, France, 15-18 February 2017.
Disclaimer:
Images and readings are for illustration purpose only.
Please read and understand the following information related to the use of the FreeStyle Libre Flash Glucose Monitoring System and consult your healthcare provider for any clarifications or queries related to your treatment of diabetes:
Indication for use:
The FreeStyle Libre Flash Glucose Monitoring System is indicated for measuring interstitial fluid glucose levels in people (age 4 and older) with diabetes mellitus. The indication for children (age 4 - 17) is limited to those who are supervised by a caregiver who is at least 18 years of age.
It is designed to replace blood glucose testing in the self-management of diabetes with the exceptions listed below. Under the following circumstances, use a blood glucose meter to check the current glucose readings from the FreeStyle Libre Flash Glucose Monitoring System Sensor.
Conditions when a blood glucose test with finger prick is required:
During times of rapidly changing glucose levels, interstitial glucose levels as measured by the sensor and reported as current may not accurately reflect blood glucose levels. When glucose levels are falling rapidly, glucose readings from the Sensor may be higher than blood glucose levels. Conversely when glucose levels are rising rapidly, glucose readings from the sensor may be lower than blood glucose levels.
In order to confirm hypoglycemia or impending hypoglycemia as reported by the sensor.
If symptoms do not match the FreeStyle Libre Flash Glucose Monitoring System reading. Do not ignore symptoms that may be due to low blood glucose or high blood glucose.
This information is provided as a supplement to the Detailed User Manual and Quick Start Guide available in your FreeStyle Libre Reader pack and not as a replacement for either.
By clicking YES, you confirm that you have read the information contained in this window and understand the indicated use of the FreeStyle Libre Flash Glucose Monitoring System.
Please click NO if you wish to remove the FreeStyle Libre Reader from your shopping cart.
You are about to exit the Abbott family of websites for 3rd party website links which take you out of Abbott worldwide websites that are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.